Q/C Technologies (QCLS) vs Trinity Biotech (TRIB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Trinity Biotech is the larger company by market cap ($5.4 million vs $5.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | QCLS | TRIB |
|---|---|---|
| Share price | $0.6151 | $6.70 |
| Market cap | $5.04M | $5.45M |
| 1-day change | -3.39% | +10.93% |
| P/E ratio (TTM) | 0.23 | — |
| EPS (TTM) | $2.62 | $-60.00 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.17 | $52.50 |
| 52-week low | $0.42 | $5.01 |
| Distance from 52-week high | -92.47% | -87.24% |
| Average volume | 4.98M | 21.66K |
| Shares outstanding | 8.19M | 813.13K |
| Employees | 3 | 287 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Q/C Technologies
QCLS stock →Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 3 employees
About Trinity Biotech
TRIB stock →Trinity Biotech plc, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Asia, Africa, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases, such as syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic measurement of haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 287 employees
QCLS vs TRIB FAQ
Which is bigger, Q/C Technologies or Trinity Biotech?
Trinity Biotech (TRIB) is larger, with a market capitalization of $5.45M compared with $5.04M for Q/C Technologies (QCLS).
Are Q/C Technologies and Trinity Biotech in the same industry?
Yes. Both are classified in the Biotechnology: In Vitro & In Vivo Diagnostic Substances industry within the Health Care sector.